Ratings by Oppenheimer (Esther Rajavelu)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/4/2020 | GW Pharma | GWPH | Maintain | Outperform (N/A) |
|
Details | ||
| 6/1/2020 | GW Pharma | GWPH | Maintain | Outperform (N/A) |
|
Details | ||
| 5/8/2020 | Arrowhead Research | ARWR | Upgrade | Outperform (Perform) |
35.13 (87.11) |
147.96% | Details | |
| 5/1/2020 | NovoCure Ltd. | NVCR | Downgrade | Perform (Outperform) |
65.80 (17.10) |
-74.01% | Details | |
| 4/23/2020 | Pfenex Inc. | PFNX | New Coverage | Outperform (N/A) |
6.09 (12.75) |
109.36% | Details | |
| 4/13/2020 | Aerie Pharma | AERI | Maintain | Outperform (N/A) |
|
Details | ||
| 4/1/2020 | Orchard Therapeutics | ORTX | Maintain | Outperform (N/A) |
|
Details | ||
| 3/16/2020 | Vanda Pharmaceuticals | VNDA | Downgrade | Underperform (Perform) |
10.24 (5.28) |
-48.44% | Details | |
| 3/10/2020 | Kala Pharmaceuticals | KALA | Maintain | Outperform (N/A) |
|
Details | ||
| 2/28/2020 | Orchard Therapeutics | ORTX | Maintain | Outperform (N/A) |
|
Details | ||
| 2/28/2020 | NovoCure Ltd. | NVCR | Maintain | Outperform (N/A) |
|
Details | ||
| 2/27/2020 | Vanda Pharmaceuticals | VNDA | Maintain | Perform (N/A) |
|
Details | ||
| 2/21/2020 | Aerie Pharma | AERI | Maintain | Outperform (N/A) |
|
Details | ||
| 2/21/2020 | Aerie Pharma | AERI | Maintain | Outperform (N/A) |
|
Details | ||
| 2/13/2020 | Teva Pharma | TEVA | Maintain | Outperform (N/A) |
|
Details | ||
| 2/13/2020 | Teva Pharma | TEVA | Maintain | Outperform (N/A) |
|
Details | ||
| 2/10/2020 | Biohaven Pharmaceutical Holding | BHVN | Downgrade | Perform (Outperform) |
51.25 (13.85) |
-72.98% | Details | |
| 2/4/2020 | Teva Pharma | TEVA | Maintain | Outperform (N/A) |
|
Details | ||
| 2/3/2020 | Eyenovia | EYEN | Downgrade | Perform (Outperform) |
4.68 (15.82) |
238.03% | Details | |
| 1/9/2020 | Jazz Pharmaceuticals | JAZZ | Maintain | Outperform (N/A) |
|
Details | ||
| 12/24/2019 | Otonomy | OTIC | New Coverage | Outperform (N/A) |
2.47 (0.08) |
-96.76% | Details | |
| 12/13/2019 | Ionis Pharmaceuticals | IONS | New Coverage | Outperform (N/A) |
61.69 (59.74) |
-3.16% | Details | |
| 12/13/2019 | Arrowhead Research | ARWR | New Coverage | Perform (N/A) |
68.22 (35.13) |
-48.5% | Details | |
| 12/9/2019 | Rocket Pharmaceuticals | RCKT | Maintain | Outperform (N/A) |
|
Details | ||
| 11/18/2019 | Kala Pharmaceuticals | KALA | Maintain | Outperform (N/A) |
|
Details | ||
| 11/7/2019 | Aerie Pharma | AERI | Maintain | Outperform (N/A) |
|
Details | ||
| 11/6/2019 | Jazz Pharmaceuticals | JAZZ | Maintain | Outperform (N/A) |
|
Details | ||
| 11/6/2019 | GW Pharma | GWPH | Maintain | Outperform (N/A) |
|
Details | ||
| 11/6/2019 | GW Pharma | GWPH | Maintain | Outperform (N/A) |
|
Details | ||
| 11/1/2019 | NovoCure Ltd. | NVCR | Maintain | Outperform (N/A) |
|
Details | ||
| 10/31/2019 | NovoCure Ltd. | NVCR | Maintain | Outperform (N/A) |
|
Details | ||
| 10/22/2019 | Teva Pharma | TEVA | Maintain | Outperform (N/A) |
|
Details | ||
| 10/9/2019 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Outperform (N/A) |
|
Details | ||
| 10/1/2019 | Eyenovia | EYEN | Maintain | Outperform (N/A) |
|
Details | ||
| 10/1/2019 | Eyenovia | EYEN | Maintain | Outperform (N/A) |
|
Details | ||
| 9/27/2019 | GW Pharma | GWPH | Maintain | Outperform (N/A) |
|
Details | ||
| 9/26/2019 | Jazz Pharmaceuticals | JAZZ | Maintain | Outperform (N/A) |
|
Details | ||
| 9/13/2019 | NovoCure Ltd. | NVCR | Maintain | Outperform (N/A) |
|
Details | ||
| 8/30/2019 | Orchard Therapeutics | ORTX | New Coverage | Outperform (N/A) |
13.56 (16.70) |
23.16% | Details | |
| 8/13/2019 | Rocket Pharmaceuticals | RCKT | Maintain | Outperform (N/A) |
|
Details | ||
| 8/7/2019 | Kala Pharmaceuticals | KALA | Maintain | Outperform (N/A) |
|
Details | ||
| 8/7/2019 | GW Pharma | GWPH | Maintain | Outperform (N/A) |
|
Details | ||
| 7/26/2019 | NovoCure Ltd. | NVCR | Maintain | Outperform (N/A) |
|
Details | ||
| 7/22/2019 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Outperform (N/A) |
|
Details | ||
| 7/19/2019 | NovoCure Ltd. | NVCR | Maintain | Outperform (N/A) |
|
Details | ||
| 7/19/2019 | NovoCure Ltd. | NVCR | Maintain | Outperform (N/A) |
|
Details | ||
| 7/8/2019 | Jazz Pharmaceuticals | JAZZ | Maintain | Outperform (N/A) |
|
Details | ||
| 7/8/2019 | Jazz Pharmaceuticals | JAZZ | Maintain | Outperform (N/A) |
|
Details | ||
| 6/28/2019 | NovoCure Ltd. | NVCR | New Coverage | Outperform (N/A) |
56.80 (17.10) |
-69.89% | Details | |
| 6/19/2019 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Outperform (N/A) |
|
Details | ||
| 6/12/2019 | Teva Pharma | TEVA | Maintain | Outperform (N/A) |
|
Details | ||
| 6/3/2019 | Teva Pharma | TEVA | Upgrade | Outperform (Perform) |
8.65 (9.61) |
11.1% | Details | |
| 5/23/2019 | Kempharm | KMPH | Maintain | Outperform (N/A) |
|
Details | ||
| 5/9/2019 | Aerie Pharma | AERI | Maintain | Outperform (N/A) |
|
Details | ||
| 5/8/2019 | Jazz Pharmaceuticals | JAZZ | Maintain | Outperform (Outperform) |
|
Details | ||
| 5/7/2019 | GW Pharma | GWPH | Upgrade | Outperform (Perform) |
180.09 (218.96) |
21.58% | Details | |
| 4/29/2019 | GW Pharma | GWPH | Maintain | Perform (N/A) |
|
Details | ||
| 4/29/2019 | GW Pharma | GWPH | Maintain | Perform (N/A) |
|
Details | ||
| 4/25/2019 | Kala Pharmaceuticals | KALA | New Coverage | Outperform (N/A) |
7.55 (0.82) |
-89.14% | Details | |
| 4/25/2019 | Eyenovia | EYEN | New Coverage | Outperform (N/A) |
6.24 (4.68) |
-25% | Details | |
| 4/15/2019 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Outperform (N/A) |
|
Details | ||
| 3/1/2019 | Kempharm | KMPH | Maintain | Outperform (N/A) |
|
Details | ||
| 2/14/2019 | Vanda Pharmaceuticals | VNDA | Maintain | Perform (N/A) |
|
Details | ||
| 2/12/2019 | Jazz Pharmaceuticals | JAZZ | Maintain | Outperform (N/A) |
|
Details | ||
| 2/5/2019 | Rocket Pharmaceuticals | RCKT | New Coverage | Outperform (N/A) |
14.30 (3.51) |
-75.45% | Details | |
| 12/12/2018 | GW Pharma | GWPH | New Coverage | Perform (N/A) |
122.78 (180.09) |
46.68% | Details | |
| 12/12/2018 | Jazz Pharmaceuticals | JAZZ | New Coverage | Outperform (N/A) |
139.65 (254.28) |
82.08% | Details | |
| 12/11/2018 | Vanda Pharmaceuticals | VNDA | Downgrade | Perform (Outperform) |
27.60 (10.24) |
-62.9% | Details | |
| 11/15/2018 | Kempharm | KMPH | Maintain | Outperform (N/A) |
|
Details | ||
| 11/13/2018 | Biohaven Pharmaceutical Holding | BHVN | New Coverage | Outperform (N/A) |
38.92 (51.25) |
31.68% | Details | |
| 11/13/2018 | Aerie Pharma | AERI | New Coverage | Outperform (N/A) |
47.76 (15.25) |
-68.07% | Details | |
| 9/21/2018 | Kempharm | KMPH | New Coverage | Outperform (N/A) |
4.95 (5.81) |
17.37% | Details | |
| 9/21/2018 | Teva Pharma | TEVA | New Coverage | Perform (N/A) |
24.64 (8.65) |
-64.89% | Details | |
| 9/21/2018 | Vanda Pharmaceuticals | VNDA | New Coverage | Outperform (N/A) |
19.65 (27.60) |
40.46% | Details |
